Call to extend hepatitis C drugs access after £190m funding boost
By Will Hazell2015-06-17T10:18:00
A charity has called for NHS England to allow all hepatitis C patients to access new treatments. It comes after the arm’s length body announced a much delayed commissioning policy for cirrhosis.
You need to be signed in to read more
Subscribe for unlimited access
With a HSJ subscription you’ll unlock:
- All of HSJ.co.uk and our HSJ mobile app
- News and insight on all areas of public funded healthcare
- Expert commentary, insight and analysis from industry leaders
- 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud